Monopar Therapeutics
MNPR
#7103
Rank
โ‚ฌ0.44 B
Marketcap
66,85ย โ‚ฌ
Share price
3.69%
Change (1 day)
208.04%
Change (1 year)

Monopar Therapeutics (MNPR) - Total assets

Total assets on the balance sheet as of June 2025 : โ‚ฌ46.03 Million

According to Monopar Therapeutics's latest financial reports the company's total assets are โ‚ฌ46.03 Million. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Monopar Therapeutics - Total assets on balance sheet (from 2017 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚ฌ57.93 M771.98%
2023-12-31โ‚ฌ6.64 M-46.12%
2022-12-31โ‚ฌ12.33 M-31.95%
2021-12-31โ‚ฌ18.12 M32.13%
2020-12-31โ‚ฌ13.71 M15.06%
2019-12-31โ‚ฌ11.91 M86.33%
2018-12-31โ‚ฌ6.39 M-22.72%
2017-12-31โ‚ฌ8.27 M200.67%
2016-12-31โ‚ฌ2.75 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚ฌ0.36 B 700.49%๐Ÿ‡บ๐Ÿ‡ธ USA